SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?


To: LWolf who wrote (3694)6/24/1998 12:29:00 AM
From: Anthony Wong  Read Replies (1) | Respond to of 9523
 
Laura and all, the Motley Fool's Evening News' take on the price drop:

Pfizer (NYSE:PFE - news) fell $1 3/8 to $110 1/8 on news that another major health management company has decided it won't pay for the drug company's hot-selling impotence pill Viagra under its regular coverage. Last week, Kaiser Permanente, which has 9.1 million members, said it would stop coverage of Viagra but that employers would be able to buy supplemental coverage for Viagra as well as other drugs for sexual dysfunction. Now, according to The Wall Street Journal, Aetna
Inc.'s (NYSE:AET - news) Aetna/U.S. Healthcare managed care unit, which has 13.7 million members, won't cover Viagra but will give employers the option of paying more to cover the drug, like it does for coverage of birth control pills. These decisions not to cover Viagra may embolden other large insurers that are still pondering whether they will cover the drug to lower the axe on Viagra. PacifiCare Health Systems (Nasdaq:PHSYA - news) , Humana (NYSE:HUM - news) , and Prudential HealthCare, a unit of Prudential Insurance, all have installed interim policies that don't allow coverage. Cigna Corp.'s (NYSE:CI - news) Cigna HealthCare now covers up to six pills a
month, while United HealthCare allows for as many as eight a month.



To: LWolf who wrote (3694)6/25/1998 12:22:00 PM
From: Anthony Wong  Read Replies (1) | Respond to of 9523
 
Pfizer to Sell Impotence Drug Viagra in Switzerland From Monday

Bloomberg News
June 25, 1998, 1:09 a.m. PT

Zurich, June 25 (Bloomberg) -- Pfizer (Schweiz) AG, a Swiss
unit of the New York-based drugmaker Pfizer Inc., said it will
begin selling its impotency treatment Viagra in Switzerland
Monday, Neue Zuercher Zeitung reported, citing SDA news agency.
Pfizer said Viagra should be treated like any other drug
prescribed by doctors, and the cost of the drug should therefore
be covered by health insurance. This week Switzerland became the
first European country, and the third nation in the world, to
allow Viagra to be sold.

More than 1 million Viagra prescriptions were written in
the U.S. within weeks of its launch in May, while in Switzerland
pharmacies began dispensing Viagra on ''emergency''
prescriptions before the drug got official approval.
(Neue Zuercher Zeitung, 6/25, 16, or www.nzz.ch)

--Tavia Grant in the Zurich newsroom (41-1) 224 4111/ab